Viewing Study NCT02194556


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT02194556
Status: UNKNOWN
Last Update Posted: 2014-07-18
First Post: 2014-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module